Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
OptiNose, Inc. (OPTN) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/18/2023 144 Form 144 - Report of proposed sale of securities:
08/18/2023 EFFECT Form EFFECT - Notice of Effectiveness:
08/10/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/10/2023 8-K Investor presentation, Quarterly results
Docs: "Optinose Reports Second Quarter 2023 Financial Results and Operational Updates Optinose Reports Second Quarter 2023 Financial Results and Operational Updates Optinose Reports Second Quarter 2023 Financial Results and Operational Updates",
"Q2 2023 30.1 30.9 Q2"
07/27/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Optinose Announces Preliminary Second Quarter 2023 XHANCE Net Revenue of $19.5 Million"
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/11/2023 8-K Investor presentation, Quarterly results
Docs: "Optinose Reports First Quarter 2023 Financial Results and Operational Updates Optinose Reports First Quarter 2023 Financial Results and Operational Updates Optinose Reports First Quarter 2023 Financial Results and Operational Updates",
"Q1 2023 29.5 30.4 Q1"
05/04/2023 8-K Quarterly results
05/01/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/21/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
04/17/2023 8-K Quarterly results
03/28/2023 8-K Quarterly results
03/07/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/07/2023 10-K Annual Report for the period ended December 31, 2022
03/07/2023 8-K Investor presentation, Quarterly results
Docs: "Optinose Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Operational Highlights",
"2 0 2 3 EXHIBIT 99.2"
02/14/2023 SC 13G/A GREAT POINT PARTNERS LLC reports a 10% stake in OPTINOSE, INC.
02/14/2023 SC 13D/A MVM Partners, LLC reports a 14.9% stake in OPTINOSE, INC.
02/09/2023 SC 13G/A FMR LLC reports a 13.3% stake in OPTINOSE INC
01/31/2023 8-K Appointed a new director
Docs: "AMENDED AND RESTATED EMPLOYMENT AGREEMENT",
"SEPARATION AGREEMENT AND GENERAL RELEASE",
"Main +1 267 364 3500 Fax +1 267 395 2119 www.optinose.com",
"Optinose Announces CEO Transition and Business Update Ramy Mahmoud, MD, MPH appointed CEO and to the Board of Directors"
01/19/2023 SC 13G/A KRUTTSCHNITT THEODORE H III has filed a Schedule 13D for OptiNose, Inc.
12/16/2022 8-K Quarterly results
12/15/2022 8-K Quarterly results
12/09/2022 8-K Quarterly results
12/05/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
12/01/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
11/23/2022 8-K Quarterly results
11/23/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
11/23/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
11/21/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
11/21/2022 8-K Quarterly results
11/10/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/10/2022 8-K Quarterly results
09/27/2022 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "EMPLOYMENT AGREEMENT",
"EMPLOYMENT AGREEMENT"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy